Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance

Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance


Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background.

Nurphoto | Nurphoto | Getty Images

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market.

Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

The company said it now expects full-year sales growth of 8% to 14% at constant exchange rates, down from a prior target of 13% to 21%.

It expects annual operating profit growth of 10% to 16% versus the previously estimated target of 16% to 24%, also at constant exchange rates.

Novo Nordisk said the lower outlook was driven by weaker second-half U.S. sales growth forecasts for its Wegovy weight loss drug and Ozempic diabetes treatment.

“For Wegovy in the US, the sales outlook reflects the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition,” it added in a statement.

This is a developing story. Please check back for updates.



Source

U.S. economy grew at a 3% rate in Q2, a better-than-expected pace even as Trump’s tariffs hit
World

U.S. economy grew at a 3% rate in Q2, a better-than-expected pace even as Trump’s tariffs hit

Shipping containers are stacked on the Ever Magic container ship operated by Evergreen at the Port of Los Angeles on June 25, 2025 in Los Angeles, California. Mario Tama | Getty Images The U.S. economy grew at a much better than expected pace in the second quarter, powered by a turnaround in the trade balance […]

Read More
Why the U.S.-EU trade agreement is unlikely to derail Europe’s defense boom
World

Why the U.S.-EU trade agreement is unlikely to derail Europe’s defense boom

Europe’s defense stocks wobbled at the start of the week, as investors pored over the details — still lacking in some areas — of the framework trade agreement struck by the U.S. and European Union on Sunday. An initial concern was that a commitment by the EU to increase its purchases of U.S. goods, in […]

Read More
Luxury carmakers flag combined costs of 9 million as U.S. tariffs bite
World

Luxury carmakers flag combined costs of $889 million as U.S. tariffs bite

Key Points Luxury carmakers Porsche, Mercedes-Benz Group and Aston Martin on Wednesday each outlined the extent to which U.S. import tariffs have taken their toll. Collectively, the carmakers warned of combined costs exceeding 770 million euros ($889 million). “This is not a storm that will pass,” Oliver Blume, chairman of the executive board of Porsche, […]

Read More